E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/25/2008 in the Prospect News PIPE Daily.

New Issue: Echo Therapeutics plans $2 million private placement of notes

By Devika Patel

Knoxville, Tenn., March 25 - Echo Therapeutics, Inc. said it will raise $2 million from a private placement of senior secured notes with Imperium Master Fund, Ltd.

The deal will settle in four equal tranches of $500,000. Echo said the first tranche already has settled and the remaining tranches will settle on April 24, May 24 and June 24. Echo must give 10 days notice if it plans to cancel one of those tranches.

The notes mature in one year and carry a 10% coupon, which is compounded monthly and payable at maturity. Each note will accrue $552,356 in interest.

Echo has the right to repay the notes' principal in cash, in whole but not in part, prior to maturity at a premium of 1.02 times the unpaid principal plus interest.

If at any time before maturity, Echo completed a private placement of $5 million or more, the notes' maturity will be extended to two years and the coupon will be reduced to 9%, with $546,903 payable at maturity.

Imperium also received warrants for 634,920 common shares, exercisable at $2.00 for five years.

Franklin, Mass.-based Echo Therapeutics is a dual platform-enabled, specialty therapeutics and diagnostics company.

Issuer:Echo Therapeutics, Inc.
Issue:Senior secured notes
Amount:$2 million
Maturity:One year
Coupon:10%
Price:Par
Yield:10%
Warrants:For 634,920 shares
Warrant expiration:Five years
Warrant strike price:$2.00
Investor:Imperium Master Fund, Ltd.
Pricing date:March 25
Settlement date:March 25 (for $500,000), April 24 (for $500,000), May 24 (for $500,000), June 24 (for $500,000)
Stock symbol:OTCBB: ECTE
Stock price:$1.55 at close March 24

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.